Corresponding Author: Jennifer I. Lim, MD, Department of Ophthalmology and Visual Sciences, Illinois Eye and Ear Infirmary, University of Illinois at Chicago, 1855 W Taylor St, Ste 2.50, Mail Code 648, Chicago, IL 60612 (jennylim@uic.edu).
Published Online: May 27, 2021. doi:10.1001/jamaophthalmol.2020.5292
Conflict of Interest Disclosures: Dr Lim reported receiving grants from Aldeyra, Chengdu, Clearside, Genentech, Graybug, Janssen, NGM, Regeneron, and Stealth and personal fees from Alcon, Allergan, Aura Biosciences, Cognition Therapeutics, Eyenuk, Genentech, Iveric Biosciences, Kodiak, Luxa, Novartis, Ophthea, pSivida (now EyePoint Pharmaceuticals, Inc), Quark, and Santen outside of the submitted work.
Disclaimer: Dr Lim is an Associate Deputy Editor of JAMA Ophthalmology, but she was not involved in any of the decisions regarding review of the manuscript or its acceptance.
Additional Contributions: We thank the patient for granting permission to publish this information.